Both in Pharmaceuticals
AYTU BioPharma vs Seres Therapeutics
Over the past year AYTU returned −12.2% and MCRB returned −88.0%; their daily moves had a correlation of 0.12.
AYTU −12.2% MCRB −88.0%Growth of $1, one year, split-adjusted
| Metric | AYTU | MCRB |
|---|---|---|
| Price | $1.94 | $1.83 |
| Market cap | $21.1M | $18.4M |
| Today | +0.52% | +3.39% |
| 1 month | −6.3% | −37.8% |
| 6 months | −23.9% | −76.2% |
| Year to date | −25.4% | −87.7% |
| 1 year | −12.2% | −88.4% |
| Revenue growth (YoY) | +6.4% | — |
| Gross margin | 64.6% | 100.0% |
| Net margin | −0.1% | 622.4% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 9.8× |
| Net cash | $9.3M | $15.6M |
| Dividend yield | — | — |
| Volatility (60d) | 37.0% | 71.0% |
| Short % of float | 3.6% | 4.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).